A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine

Completed · Phase 3

Conditions studied: SARS-CoV-2 Infection

In brief

The purpose of this study is to assess SARS CoV-2 infection, viral shedding, and subsequent potential transmission in individuals immunized with the Moderna COVID-19 vaccine.

Key facts

Study ID
NCT04811664
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
1923
Starts
2021-03-24
Expected to finish
2021-12-30
Last updated by the study team
2023-08-02

Who can join

Age: 18 and older, up to 29. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.